• Aucun résultat trouvé

P19-25. A vaccine model to prevent the depletion of uninfected bystander CD4 cells during HIV infection

N/A
N/A
Protected

Academic year: 2021

Partager "P19-25. A vaccine model to prevent the depletion of uninfected bystander CD4 cells during HIV infection"

Copied!
2
0
0

Texte intégral

(1)

HAL Id: inserm-00663919

https://www.hal.inserm.fr/inserm-00663919

Submitted on 27 Jan 2012

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of

sci-entific research documents, whether they are

pub-lished or not. The documents may come from

teaching and research institutions in France or

abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est

destinée au dépôt et à la diffusion de documents

scientifiques de niveau recherche, publiés ou non,

émanant des établissements d’enseignement et de

recherche français ou étrangers, des laboratoires

publics ou privés.

P19-25. A vaccine model to prevent the depletion of

uninfected bystander CD4 cells during HIV infection

Vincent Vieillard, Hugues Fausther-Bovendo, Roger Le Grand, Patrice Debre

To cite this version:

Vincent Vieillard, Hugues Fausther-Bovendo, Roger Le Grand, Patrice Debre. P19-25. A vaccine

model to prevent the depletion of uninfected bystander CD4 cells during HIV infection. AIDS Vaccine

2009, Oct 2009, Paris, France. pp.P345, �10.1186/1742-4690-6-S3-P345�. �inserm-00663919�

(2)

BioMed Central

Page 1 of 1

(page number not for citation purposes)

Retrovirology

Open Access

Poster presentation

P19-25. A vaccine model to prevent the depletion of uninfected

bystander CD4 cells during HIV infection

V Vieillard*

1

, H Fausther-Bovendo

1

, R Le Grand

2

and P Debre

1 Address: 1INSERM UMR945, Paris, France and 2Neuro Virologie, CEA-DSV/DRM, Fontenay-aux-Roses, France * Corresponding author

Background

The CD4 depletion in the chronic phase of HIV infection is mostly due to the loss of uninfected cells. We recently showed that the expression of NKp44L, a cellular ligand of an activating NK receptor was exclusively expressed on non-infected CD4 cells from HIV-infected patients. NKp44L is specially induced by the highly conserved 3S motif of the HIV-1 gp41 envelope protein. In this study we sought to determine whether the loss of uninfected bystander CD4 cells could be prevented by an anti-3S vac-cine.

Methods

Ten cynomolgus macaques were primed/boosted in IFA with 3S-KLH or free KLH, as control. Sixteen weeks after the last immunization, all animals were challenged IV with the SHIV162P3. Peripheral and lymphoid lym-phocyte samples were periodically tested.

Results

We discovered that 1) During HIV infection, uninfected CD4 cells exclusively express NKp44L; 2) In a macaque model of SHIV162P3 infection, a 3S-KLH immunization significantly decreases NKp44L expression on CD4 cells, NK cells cytotoxicity and apoptosis, when compared to infected control group immunized with free KLH. Inter-estingly, the CD4 cells level of immunized animals remains stable, while it decreased in the control group.

Conclusion

These results emphasize the deleterious role of NK cells on the depletion of uninfected bystander CD4 cells. They

also present new opportunities for HIV vaccine strategies, which should subsequently inhibits and/or delay the dis-ease evolution to AIDS.

from AIDS Vaccine 2009

Paris, France. 19–22 October 2009 Published: 22 October 2009

Retrovirology 2009, 6(Suppl 3):P345 doi:10.1186/1742-4690-6-S3-P345

<supplement> <title> <p>AIDS Vaccine 2009</p> </title> <editor>Anna Laura Ross</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S3-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf</url> </supplement>

This abstract is available from: http://www.retrovirology.com/content/6/S3/P345 © 2009 Vieillard et al; licensee BioMed Central Ltd.

Références

Documents relatifs

We report the case of a patient with a very profound CD4-T cell lymphopenia below 20 cells/mm 3 in the context of a primary HIV-1 infection, associated with both delayed

We studied a group of Central African individuals who remained apparently uninfected despite repeated unpro- tected sex intercourses with their HIV-1-infected partners (EUs). We found

It is noteworthy in this respect that heterozygous CCR5 mutations in two of the five EUs studied here (B184 and W336) were associated with low CCR5 surface expression on their

(A) Classical monocyte (CD14 ++ CD16 − ) percentages among CD45 + PBMC and (B) absolute counts/µL blood, (C) intermediate monocyte CD14 + CD16 + percentages and (D) absolute counts /

Fungus- stimulated MDDCs significantly enhanced the capacity to mediate HIV-luc/JRFL or HIV-luc/NL4-3 trans infection of HutCCR5 cells, there was a 4.8- to 6.5-fold increase

 ISSEA, Institut Sous-régional de Statistique et d'Économie Appliquée de Yaoundé  ENSAE, École Nationale de la Statistique et de l'Analyse Économique de Dakar  ENEAM,

In this study, we formulated a multiscale model of an acute HIV infection, which integrates the processes of infection spread and immune responses in lymph nodes and links to

Vu le manque de preuves et la vulnérabilité de cette population, le CBIP rappelle que les statines doivent être prescrites avec prudence et que la prescription ou la déprescription